Larsson S, Svedmyr N
Am Rev Respir Dis. 1977 Nov;116(5):861-9. doi: 10.1164/arrd.1977.116.5.861.
Effects and side effects of an adrenergic beta2-stimulant (salbutamol) given by mouth and by inhalation from a metered aerosol were compared. Cumulative dose-response curves for both routes of administration concerning 1-sec forced expiratory volume, forced vital capacity, heart rate, blood pressure, and tremor were constructed. Tremor was found to be the dose-limiting side effect with both modes of administration. The metered aerosol in doses as large as 0.6 mg was shown to produce a greater increase in the 1-sec forced expiratory volume, with fewer side effects than could be achieved with tolerable doses of salbutamol by mouth. An oral dose of 6 mg is probably the maximal tolerable dose in most cases. Oral treatment seems to have a better effect than inhalation treatment on the forced vital capacity at the same effect on 1-sec forced expiratory volume, possibly due to a better effect on small peripheral airways. The effect of combining different oral doses of salbutamol with inhaled salbutamol was also studied. A very good additional effect of inhalations given after 4 and 6 mg by mouth was shown.
比较了口服和通过定量气雾剂吸入肾上腺素能β2激动剂(沙丁胺醇)的效果和副作用。构建了两种给药途径关于1秒用力呼气量、用力肺活量、心率、血压和震颤的累积剂量-反应曲线。发现震颤是两种给药方式的剂量限制性副作用。高达0.6毫克剂量的定量气雾剂显示出能使1秒用力呼气量有更大增加,且副作用比口服可耐受剂量的沙丁胺醇更少。在大多数情况下,口服6毫克可能是最大可耐受剂量。在对1秒用力呼气量有相同效果时,口服治疗似乎比对用力肺活量的吸入治疗效果更好,这可能是由于对小的外周气道有更好的效果。还研究了将不同口服剂量的沙丁胺醇与吸入性沙丁胺醇联合使用的效果。结果显示,口服4毫克和6毫克后进行吸入有非常好的附加效果。